Pure Global
NCT06394544

Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment

Effects of Brazil Nut Supplementation on Inflammation, Oxidative Stress and Microbiota in Patients With Chronic Kidney Disease Undergoing Conservative Treatment
Universidade Federal Fluminense·ClinicalTrials.gov·dietary supplementNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Chronic Kidney Diseases,Chronic Kidney Disease stage3,Chronic Kidney Disease Stage 3A,Chronic Kidney Disease Stage 3B,Chronic Kidney Disease stage4,Inflammation,Inflammatory Response,Oxidative Stress,Intestinal Microbiota
Drug/Device/Intervention
Brazil Nut
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Universidade Federal Fluminense
Location
Rio de Janeiro, Brazil
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2024
End date
Mar 01, 2027
Enrollment
50 participants
Primary outcome

Change in antioxidants and anti-inflammatory biomarkers

Summary

The aim of this study is to evaluate the effects of Brazil nut supplementation on
 inflammation, oxidative stress and intestinal microbiota in patients with chronic kidney
 disease undergoing conservative treatment.

ICD-10 classifications
Chronic kidney disease, stage 3Chronic kidney disease, stage 1Chronic kidney disease, stage 4Chronic kidney disease, stage 5Chronic kidney disease, stage 2
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06394544
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06394544 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidade Federal Fluminense and is currently Not yet recruiting. The study focuses on Chronic Kidney Diseases,Chronic Kidney Disease stage3,Chronic Kidney Disease Stage 3A,Chronic Kidney Disease Stage 3B,Chronic Kidney Disease stage4,Inflammation,Inflammatory Response,Oxidative Stress,Intestinal Microbiota. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.